{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:53:23Z","timestamp":1770893603672,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ebiom.2020.103031","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T07:56:32Z","timestamp":1602230192000},"page":"103031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma"],"prefix":"10.1016","volume":"61","author":[{"given":"Bill T.V.","family":"Duong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Bavaghar-Zaeimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4565-2056","authenticated-orcid":false,"given":"Mahmoud","family":"Labib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.P.","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thurgaa","family":"Jeganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Pantea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana O.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.103031_bib0001","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S1470-2045(18)30100-1","article-title":"Novel therapies for malignant pleural mesothelioma","volume":"19","author":"Scherpereel","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0002","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and new frontiers in mesothelioma therapeutics","volume":"13","author":"Mutti","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0003","first-page":"1","article-title":"Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma","volume":"3","author":"Zhang","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0004","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.03.97","article-title":"Overview of treatment related complications in malignant pleural mesothelioma","volume":"5","author":"Murphy","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0005","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ebiom.2020.103031_bib0006","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijsu.2017.10.034","article-title":"The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database","volume":"48","author":"Wang","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.ebiom.2020.103031_bib0007","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2016.09.003","article-title":"Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group","volume":"101","author":"Armato","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ebiom.2020.103031_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0004563217741145","article-title":"Biomarkers in mesothelioma","volume":"55","author":"Arnold","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ebiom.2020.103031_bib0009","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"Cristaudo","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study","volume":"17","author":"Amati","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ebiom.2020.103031_bib0011","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e318187491c","article-title":"Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer","volume":"3","author":"Schneider","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0012","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.103031_bib0013","doi-asserted-by":"crossref","first-page":"84851","DOI":"10.18632\/oncotarget.12707","article-title":"Diagnostic value of fibulin-3 for malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2020.103031_bib0014","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.18632\/oncotarget.14712","article-title":"Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis","volume":"8","author":"Pei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2020.103031_bib0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0016","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060203","article-title":"Biomarkers for early diagnosis and prognosis of malignant pleural mesothelioma: The quest goes on","volume":"10","author":"Ledda","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ebiom.2020.103031_bib0018","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bjc.2017.22","article-title":"Prognostication and monitoring of mesothelioma using biomarkers: a systematic review","volume":"116","author":"Arnold","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2020.103031_bib0019","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/carcin\/bgz103","article-title":"Biomarkers for malignant pleural mesothelioma: a meta-analysis","volume":"40","author":"Gillezeau","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ebiom.2020.103031_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/atm.2017.06.60","article-title":"Diagnosis and prognosis-review of biomarkers for mesothelioma","volume":"5","author":"Sun","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0021","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1007\/s13277-015-4063-1","article-title":"Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma","volume":"36","author":"Liu","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19010238","article-title":"Heterogeneous contributing factors in MPM disease development and progression: Biological advances and clinical implications","volume":"19","author":"Tolani","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2020.103031_bib0023","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"Mapara","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0024","first-page":"426","article-title":"Acute injury and regeneration of the mesothelium in response to asbestos fibers","volume":"128","author":"Moalli","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jtho.2016.07.033","article-title":"Malignant mesothelioma effusions are infiltrated by CD3+ T cells highly expressing PD-L1 and the PD-L1+ tumor cells within these effusions are susceptible to ADCC by the anti-PD-L1 antibody avelumab","volume":"11","author":"Khanna","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0026","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/JTO.0b013e3182208ee0","article-title":"Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model","volume":"6","author":"Wu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0027","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ebiom.2020.103031_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ebiom.2020.103031_bib0029","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1073\/pnas.1106645108","article-title":"Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells","volume":"108","author":"Jinushi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2020.103031_bib0030","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2020.103031_bib0031","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ncb2610","article-title":"Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature","volume":"14","author":"Rinkevich","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0032","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1582-4934.2010.01087.x","article-title":"Peritoneal repairing cells: A type of bone marrow derived progenitor cells involved in mesothelial regeneration","volume":"15","author":"Carmona","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0033","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1039\/c3lc90136j","article-title":"Rare cell isolation and analysis in microfluidics","volume":"14","author":"Chen","year":"2014","journal-title":"Lab Chip."},{"key":"10.1016\/j.ebiom.2020.103031_bib0034","doi-asserted-by":"crossref","first-page":"25683","DOI":"10.1021\/acsami.7b04677","article-title":"Amplified Micromagnetic Field Gradients Enable High-Resolution Profiling of Rare Cell Subpopulations","volume":"9","author":"Poudineh","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ebiom.2020.103031_bib0035","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/jacs.5b10939","article-title":"Aptamer and antisense-mediated two-dimensional isolation of specific cancer cell subpopulations","volume":"138","author":"Labib","year":"2016","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ebiom.2020.103031_bib0036","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nnano.2016.239","article-title":"Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking","volume":"12","author":"Poudineh","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0037","article-title":"Ultrasensitive and rapid quantification of cardiomyocyte populations rare tumorigenic stem cell","volume":"6","author":"Wang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2020.103031_bib0038","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1039\/C8LC00310F","article-title":"Dynamic CTC phenotypes in metastatic prostate cancer models visualized using magnetic ranking cytometry","volume":"18","author":"Kermanshah","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.ebiom.2020.103031_bib0039","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41551-019-0454-8","article-title":"High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting","volume":"3","author":"Mair","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ebiom.2020.103031_bib0040","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1021\/acsami.7b05253","article-title":"Isolation of phenotypically distinct cancer cells using nanoparticle-mediated sorting","volume":"9","author":"Green","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ebiom.2020.103031_bib0041","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.8b04792","article-title":"Nanoparticle-mediated capture and electrochemical detection of methicillin-resistant staphylococcus aureus","author":"Nemr","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.ebiom.2020.103031_bib0042","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1021\/acs.analchem.9b01697","article-title":"Phenotypic profiling of circulating tumor cells in metastatic prostate cancer patients using nanoparticle-mediated ranking","volume":"91","author":"Green","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.ebiom.2020.103031_bib0043","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1021\/acsnano.8b07616","article-title":"Prismatic deflection of live tumor cells and cell clusters","volume":"12","author":"Aldridge","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ebiom.2020.103031_bib0044","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/anie.201608983","article-title":"Profiling functional and biochemical phenotypes of circulating tumor cells using a two-dimensional sorting device","volume":"56","author":"Poudineh","year":"2017","journal-title":"Angew Chemie - Int Ed"},{"key":"10.1016\/j.ebiom.2020.103031_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41557-018-0025-8","article-title":"Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping","volume":"10","author":"Labib","year":"2018","journal-title":"Nat Chem"},{"key":"10.1016\/j.ebiom.2020.103031_bib0046","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/JTO.0b013e31819f2e0e","article-title":"Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure","volume":"4","author":"Roberts","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0047","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating surgery for mesothelioma after radiation therapy: the \u2018SMART\u2019 approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0048","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0049","doi-asserted-by":"crossref","first-page":"26744","DOI":"10.18632\/oncotarget.15814","article-title":"Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma","volume":"8","author":"Inaguma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2020.103031_bib0050","first-page":"1241","article-title":"Prognostic value of FDG PET imaging in malignant pleural mesothelioma","volume":"40","author":"B\u00e9nard","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ebiom.2020.103031_bib0051","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jtho.2016.09.123","article-title":"The IASLC mesothelioma staging project: improving staging of a rare disease through international participation","volume":"11","author":"Pass","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/617421","article-title":"Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer","volume":"2010","author":"Miller","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0053","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/eji.201041117","article-title":"Thy-1 (CD90) regulates the extravasation of leukocytes during inflammation","volume":"41","author":"Schubert","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2020.103031_bib0054","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12967-014-0370-3","article-title":"An RNA editing fingerprint of cancer stem cell reprogramming","volume":"13","author":"Crews","year":"2015","journal-title":"J Transl Med"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420304072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420304072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:05:13Z","timestamp":1762455913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420304072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"alternative-id":["S2352396420304072"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103031","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103031"}}